克隆进化过程从基本血栓细胞血症到急性髓性白血病在原始患者中,从这些患者中建立了CALR突变的Marimo细胞系
Yoko Ushijima1, Yuichi Ishikawa1, Takahiro Nishiyama1,2
1Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Nagoya journal of medical science
|July 4, 2024
概括
马里莫细胞系的遗传分析显示,NRAS突变驱动精髓血栓塞瘤 (ET) 到急性髓性白血病 (AML) 的进展. 这种NRAS突变克隆的扩散导致了Marimo细胞系的建立,突出显示了MAPK通路的激活.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 马里莫细胞系来自急性髓性白血病 (AML) 转变的基本血小板血 (ET),含有CALR突变,用于ET研究.
- 之前的研究确立了Marimo细胞系,但没有分析疾病进展期间原始患者的遗传进化.
研究的目的:
- 在最初的患者中,调查从ET到AML的疾病进展的基础的顺序基因变化.
- 阐明NRAS突变克隆的选择性增殖和马里莫细胞系的建立的遗传基础.
- 确定参与马里莫细胞增殖的关键信号通路.
主要方法:
- 在疾病进展过程中对患者样本中的遗传状况进行序列分析.
- 突变的变异性等位基因频率分析.
- 在体外增殖测定.
- 基因表达分析 (MPL,JAK2-STAT,MAPK路径).
主要成果:
- 该ET克隆具有CALR和MPL突变;TP53和NRAS突变影响了ET转变为AML.
- 随着疾病的进展,NRAS突变变异样基因的频率增加,NRAS突变的克隆在体外表现出选择性的增殖.
- 尽管存在CALR和MPL突变,但MPL在马里莫细胞或临床样本中没有表达.
- 线素激活蛋白激酶 (MAPK) 途径被激活,而JAK2-STAT途径没有.
结论:
- NRAS突变在ET向AML的进展和马里莫细胞系的建立中发挥着关键作用.
- MAPK通路的激活主要负责马里莫细胞的增殖能力.
相关概念视频
Lineage Commitment
3.0K
Commitment is the process whereby stem cells:
3.0K
Cancers Originate from Somatic Mutations in a Single Cell
11.9K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
11.9K
Differentiation of Common Myeloid Progenitor Cells
3.2K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.2K
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
Bone Marrow Sampling and Transplants
323
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
323


